Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
- Exhibits and presentations in US, Latin America and Europe focus on advantages of Intelligent Clinical Development to take time and cost out of drug development. -
SAN DIEGO, Oct. 7, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global contract research organization (CRO), is participating in five industry events in October and November: BeCRO/EUCROF, Jahreskongree Klinische Pharmakologie, FierceBiotech Executive Breakfast, DIA Latin America and Partnerships in Clinical Trials. Members of SynteractHCR's senior leadership team will present at two of these conferences. In addition, the CRO is co-sponsoring an executive breakfast on Big Data in Boston.
SynteractHCR recently introduced its ICD+ platform to leverage the company's deep clinical development expertise, appropriate technology, and optimized execution to drive solution-oriented efficiencies and consistent standards on a global scale. To support ICD+, the CRO is hosting a series of webinars on ICD+ to identify ways that take time and cost out of the drug development process. The next webinar will be held in mid-December. More information on the date and speakers will be announced online.
To set an appointment, contact Matt Smith, SVP business development US, at (760) 268-8200.
About SynteractHCR (www.synteracthcr.com)
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.
©2012 PR Newswire. All Rights Reserved.